Abivax SA American Share...

6.04
-0.19 (-3.05%)
At close: Jan 23, 2025, 3:59 PM
6.08
0.58%
After-hours Jan 23, 2025, 04:00 PM EST

Abivax SA American Shares Statistics

Share Statistics

Abivax SA American Shares has 63.35M shares outstanding. The number of shares has increased by 0.7% in one year.

Shares Outstanding 63.35M
Shares Change (YoY) n/a
Shares Change (QoQ) 0.08%
Owned by Institutions (%) n/a
Shares Floating 55.10M
Failed to Deliver (FTD) Shares 37
FTD / Avg. Volume 0.03%

Short Selling Information

The latest short interest is 577.23K, so 0.91% of the outstanding shares have been sold short.

Short Interest 577.23K
Short % of Shares Out 0.91%
Short % of Float 1.05%
Short Ratio (days to cover) 4.75

Valuation Ratios

The PE ratio is -2.86 and the forward PE ratio is -3.42.

PE Ratio -2.86
Forward PE -3.42
PS Ratio 91.52
Forward PS 83
PB Ratio 2.16
P/FCF Ratio -4.34
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Abivax SA American Shares has an Enterprise Value (EV) of 220.41M.

EV / Earnings -1.49
EV / Sales 47.7
EV / EBITDA -1.65
EV / EBIT -1.73
EV / FCF -2.2

Financial Position

The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.28.

Current Ratio 4.08
Quick Ratio 4.08
Debt / Equity 0.28
Total Debt / Capitalization 22.06
Cash Flow / Debt -1.75
Interest Coverage -9.21

Financial Efficiency

Return on equity (ROE) is -0.75% and return on capital (ROIC) is -49.16%.

Return on Equity (ROE) -0.75%
Return on Assets (ROA) -0.45%
Return on Capital (ROIC) -49.16%
Revenue Per Employee 74.53K
Profits Per Employee -2.38M
Employee Count 62
Asset Turnover 0.01
Inventory Turnover -128.13

Taxes

Income Tax -4.49M
Effective Tax Rate 0.03

Stock Price Statistics

The stock price has increased by -47.43% in the last 52 weeks. The beta is 1.42, so Abivax SA American Shares's price volatility has been higher than the market average.

Beta 1.42
52-Week Price Change -47.43%
50-Day Moving Average 8.03
200-Day Moving Average 11.42
Relative Strength Index (RSI) 33.54
Average Volume (20 Days) 142.63K

Income Statement

In the last 12 months, Abivax SA American Shares had revenue of 4.62M and earned -147.74M in profits. Earnings per share was -3.43.

Revenue 4.62M
Gross Profit 3.91M
Operating Income -127.38M
Net Income -147.74M
EBITDA -133.21M
EBIT -127.38M
Earnings Per Share (EPS) -3.43
Full Income Statement

Balance Sheet

The company has 251.94M in cash and 55.46M in debt, giving a net cash position of 196.48M.

Cash & Cash Equivalents 251.94M
Total Debt 55.46M
Net Cash 196.48M
Retained Earnings -282.95M
Total Assets 327.06M
Working Capital 215.93M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -100.01M and capital expenditures -265.00K, giving a free cash flow of -100.28M.

Operating Cash Flow -100.01M
Capital Expenditures -265.00K
Free Cash Flow -100.28M
FCF Per Share -2.26
Full Cash Flow Statement

Margins

Gross margin is 97.23%, with operating and profit margins of -2.76K% and -3.20K%.

Gross Margin 97.23%
Operating Margin -2.76K%
Pretax Margin -3.29K%
Profit Margin -3.20K%
EBITDA Margin -2.88K%
EBIT Margin -2.76K%
FCF Margin -2.17K%

Dividends & Yields

ABVX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -54.88%
FCF Yield -25.32%
Dividend Details

Analyst Forecast

The average price target for ABVX is $43, which is 588% higher than the current price. The consensus rating is "Buy".

Price Target $43
Price Target Difference 588%
Analyst Consensus Buy
Analyst Count 6
Stock Forecasts

Scores

Altman Z-Score -0.54
Piotroski F-Score 2